首页|期刊导航|中国医学前沿杂志(电子版)|polyG疾病的临床与基础研究进展

polyG疾病的临床与基础研究进展OA

Clinical and basic research advances in polyG diseases

中文摘要英文摘要

聚甘氨酸(polyglycine,polyG)疾病是一类由CGG重复扩增引起的动态突变疾病,其核心致病机制在于CGG重复序列的重复相关非 AUG起始翻译产生了具有毒性的polyG蛋白.该类疾病谱包括脆性 X相关震颤/共济失调综合征、神经元核内包涵体病、眼咽远端肌病、眼咽肌病伴脑白质病及4型脊髓小脑共济失调.近年来,随着长读长测序技术的普及及应用,polyG疾病的致病基因不断被发现,其临床及病理特征日益明确.本文系统总结了polyG疾病的临床表现、病理特征、基因学发现以及其分子发病机制的研究进展,并对未来治疗策略的发展方向进行了展望.

Polyglycine(polyG)diseases are a group of dynamic mutation disorders caused by CGG repeat expansion.Their core pathogenic mechanism involves repeat associated nonAUG translation of CGG repeats,resulting in the production of toxic polyG proteins.The disease spectrum includes fragile X-associated tremor/ataxia syndrome,neuronal intranuclear inclusion disease,oculopharyngodistal myopathy,oculopharyngeal myopathy with leukoencephalopathy,and spinocerebellar ataxia type 4.In recent years,with the increasing application and maturation of longread sequencing technologies,the causative genes underlying polyG diseases have been continuously identified,leading to a clearer understanding of their clinical and pathological features.This review systematically summarizes the clinical manifestations,pathological characteristics,genetic discoveries,and molecular pathogenic mechanisms of polyG diseases,and provides an outlook on future therapeutic strategies.

高超;邓健文

北京大学第一医院神经内科,北京 100034北京大学第一医院神经内科,北京 100034||北京大学第一医院罕见病医学中心,北京 100034

聚甘氨酸疾病CGG重复扩增聚甘氨酸蛋白动态突变疾病

Polyglycine diseasesCGG repeat expansionPolyglycine proteinsDynamic mutation diseases

《中国医学前沿杂志(电子版)》 2026 (2)

1-10,10

National Natural Science Foundation of China(82422025) 国家自然科学基金项目(82422025)

10.12037/YXQY.2026.02-01

评论